 |
|
How Do Institutional Review Boards Apply the Federal Risk and Benefit Standards for Pediatric Research?
Seema Shah, BA;
Amy Whittle, BA;
Benjamin Wilfond, MD;
Gary Gensler, MS;
David Wendler, PhD
JAMA. 2004;291:476-482.
Context Federal regulations allow children in the United States to be enrolled in clinical research only when the institutional review board (IRB) determines that the risks are minimal or a minor increase over minimal, or that the research offers a prospect of direct benefit. Despite this reliance on IRBs, no data exist on how IRBs apply the risk and benefit categories for pediatric research.
Objective To determine how IRB chairpersons apply the federal risk and benefit categories for pediatric research.
Design, Setting, and Participants Telephone survey, conducted between May and August 2002 of 188 randomly selected chairpersons of IRBs in the Unites States. The survey consisted of 21 questions to assess the application of federal risk standards to research procedures, whether certain interventions offer a prospect of direct benefit to participating children, and the extent to which IRBs use the federal definition of minimal risk when categorizing the risks of research procedures in children.
Main Outcome Measures Responses regarding categorization of the risk level and direct benefits of pediatric research procedures.
Results A single blood draw was the only procedure categorized as minimal risk by a majority (152 or 81%) of the 188 respondents. An electromyogram was categorized as minimal or a minor increase over minimal risk by 100 (53%) and as more than a minor increase over minimal risk by 77 (41%). Allergy skin testing was categorized as minimal risk by 43 IRB chairpersons (23%), a minor increase over minimal risk by 81 (43%), and more than a minor increase over minimal risk by 51 (27%). Regarding benefits, 113 chairpersons (60%) considered added psychological counseling to be a direct benefit, while participant payment was considered a direct benefit by 10% (n = 19).
Conclusions Application of the federal risk and benefit categories for pediatric research by IRB chairpersons is variable and sometimes contradicted by the available data on risks and the regulations themselves. To protect children from excessive risks while allowing appropriate research, IRB chairpersons need guidance on applying the federal risk and benefit categories and also need data on the risks children face in daily life and during routine physical or psychological tests.
Author Affiliations: Department of Clinical Bioethics (Mss Shah and Whittle and Drs Wilfond and Wendler) and Human Genome Research Institute (Dr Wilfond), National Institutes of Health, Bethesda, Md; and Emmes Corporation, Bethesda, Md (Mr Gensler).
RELATED LETTERS
Improving the Decision Processes of Institutional Review Boards
Todd H. Wagner
JAMA. 2004;291(14):1698.
EXTRACT
| FULL TEXT
Improving the Decision Processes of Institutional Review Boards—Reply
David Wendler
JAMA. 2004;291(14):1698-1699.
EXTRACT
| FULL TEXT
RELATED ARTICLES
Communication of Randomization in Childhood Leukemia Trials
Eric Kodish, Michelle Eder, Robert B. Noll, Kathleen Ruccione, Beverly Lange, Anne Angiolillo, Rebecca Pentz, Stephen Zyzanski, Laura A. Siminoff, and Dennis Drotar
JAMA. 2004;291(4):470-475.
ABSTRACT
| FULL TEXT
Determining the Appropriateness of Including Children in Clinical Research: How Thick Is the Ice?
Jeremy Sugarman
JAMA. 2004;291(4):494-496.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Rethinking risk in pediatric research.
Glass and Binik
J Law Med Ethics 2008;36:567-576.
Child Versus Adult Research: The Gap in High-Quality Study Design
Martinez-Castaldi et al.
Pediatrics 2008;122:52-57.
ABSTRACT
| FULL TEXT
Empirical Data and the Acceptability of Research Risk: A Commentary on the Charitable Participation Standard
Reynolds and Nelson
Arch Pediatr Adolesc Med 2008;162:88-90.
FULL TEXT
Review of a mock research protocol in functional neuroimaging by Canadian research ethics boards.
de Champlain and Patenaude
J. Med. Ethics 2006;32:530-534.
ABSTRACT
| FULL TEXT
Trust based obligations of the state and physician-researchers to patient-subjects.
Miller and Weijer
J. Med. Ethics 2006;32:542-547.
ABSTRACT
| FULL TEXT
Emerging Empirical Evidence on the Ethics of Schizophrenia Research
Dunn et al.
Schizophr Bull 2006;32:47-68.
ABSTRACT
| FULL TEXT
Do Research Procedures Pose Relatively Greater Risk for Healthy Persons Than for Persons With Schizophrenia?
Roberts et al.
Schizophr Bull 2006;32:153-158.
ABSTRACT
| FULL TEXT
Quantifying the Federal Minimal Risk Standard: Implications for Pediatric Research Without a Prospect of Direct Benefit
Wendler et al.
JAMA 2005;294:826-832.
ABSTRACT
| FULL TEXT
Looking into the Institutional Review Board: Observations from Both Sides of the Table
Burke
J. Nutr. 2005;135:921-924.
ABSTRACT
| FULL TEXT
Eliminating the daily life risks standard from the definition of minimal risk
Resnik
J. Med. Ethics 2005;31:35-38.
ABSTRACT
| FULL TEXT
Tissue Collection for Correlative Studies in Childhood Cancer Clinical Trials: Ethical Considerations and Special Imperatives
Anderson et al.
JCO 2004;22:4846-4850.
ABSTRACT
| FULL TEXT
Task Force 1: The ACCF and AHA codes of conduct in human subjects research
Alpert et al.
J Am Coll Cardiol 2004;44:1724-1728.
FULL TEXT
Task Force 1: The ACCF and AHA Codes of Conduct in Human Subjects Research
Alpert et al.
Circulation 2004;110:2512-2516.
FULL TEXT
Improving the Decision Processes of Institutional Review Boards
Wagner
JAMA 2004;291:1698-1698.
FULL TEXT
Determining the Appropriateness of Including Children in Clinical Research: How Thick Is the Ice?
Sugarman
JAMA 2004;291:494-496.
FULL TEXT
|
